Biosearch Technologies Licenses H1N1 Flu IP from CDC

Biosearch said it is the first to license the CDC influenza signatures, and that it will manufacture and sell oligonucleotides bearing the H1N1 and influenza A sub-typing signatures.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.